Stopping insulin injections following genetic testing in diabetes: Impact on identity

Diabetic Medicine

Volumn 27, Issue 7, 2010, Pages 838-843

  Shepherd, M ^a  

^a PENINSULA MEDICAL SCHOOL   (United Kingdom)

Author keywords

biographical disruption; embodiment; genetic testing; identity; monogenic diabetes

Indexed keywords

INSULIN; SULFONYLUREA;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE DURATION; FEMALE; FOLLOW UP; GENE MUTATION; GENETIC SCREENING; HUMAN; IDENTITY; INSULIN DEPENDENT DIABETES MELLITUS; INTERVIEW; MALE; MATURITY ONSET DIABETES MELLITUS; QUALITATIVE ANALYSIS; TREATMENT REFUSAL;

ADULT; AGED; AGED, 80 AND OVER; DIABETES MELLITUS, TYPE 1; DIAGNOSIS, DIFFERENTIAL; FEMALE; GENETIC TESTING; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN; INTERVIEWS AS TOPIC; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; PHENOTYPE; SELF CONCEPT; SULFONYLUREA COMPOUNDS; WITHHOLDING TREATMENT; YOUNG ADULT;

EID: 77954248652     PISSN: 07423071     EISSN: 14645491     Source Type: Journal    
DOI: 10.1111/j.1464-5491.2010.03022.x     Document Type: Article

References (21)

1. Owen K, Hattersley AT. Maturity onset diabetes of the young: from clinical description to molecular genetic characterisation. Best Pract Res Clin Endocrinol Metab 2001 15 : 309 323.
2. Shepherd M. Recognising maturity onset diabetes of the young. J Diabetes Nurs 2001 5 : 168 172.
3. Lehto M, Tuomi T, Mahtani MM, Widen E, Forsblom C, Sarelin et al. Characterisation of the MODY3 phenotype. Early onset diabetes caused by an insulin secretion defect. J Clin Invest 1997 99 : 582 591.
4. Møller AM, Dalgaard LT, Pociot F, Nerup J, Hansen T, Pedersen O. Mutations in the hepatocyte nuclear factor-1-alpha gene in Caucasian families originally classified as having Type 1 diabetes. Diabetologia 1998 41 : 1528 1531.
5. Hathout EH, Cockburn BN, Mace JW, Sharkey J, Chen-Daniel J, Bell GI. A case of hepatocyte nuclear factor-1 alpha diabetes/MODY3 masquerading as type 1 diabetes in a Mexican-American adolescent and responsive to a low dose of sulpfonylurea. Diabetes Care 1999 22 : 867 868.
6. Lambert AP, Ellard S, Allen LI, Gallen IW, Gillespie KM, Bingley PJ. Identifying hepatic nuclear factor-1α mutations in children and young adults with a clinical diagnosis of type 1 diabetes. Diabetes Care 2003 26 : 333 337.
7. Stride A, Hattersley AT. Different genes, different diabetes: lessons from maturity onset diabetes of the young. Ann Med 2002 34 : 207 216.
8. Pearson ER, Starkey BJ, Powell RJ, Gribble FM, Clark PM, Hattersley AT. Genetic cause of hyperglycaemia and response to treatment in diabetes. Lancet 2003 362 : 1275 1281.
9. Pearson ER, Liddell WG, Shepherd M, Corrall RJ, Hattersley AT. Sensitivity to sulphonylureas in patients with hepatocyte nuclear factor-1α gene mutations: evidence for pharmacogenetics in diabetes. Diabet Med 2000 17 : 543 545.
10. Shepherd M, Pearson ER, Houghton J, Salt G, Ellard S, Hattersley AT. No deterioration in glycaemic control in HNF-1α maturity onset diabetes of the young following transfer from long-term insulin to sulphonylureas. Diabetes Care 2003 26 : 3191 3192.
11. Shepherd M, Shields B, Ellard S, Rubio-Cabezas O, Hattersley AT. A genetic diagnosis of HNF1A diabetes alters treatment and improves glycaemic control in the majority of insulin-treated patients. Diabet Med 2009 26 : 437 441.
12. Pearson ER, Pruhova S, Tack CJ, Johansen A, Castleden HA, Lumb PJ et al. Molecular genetics and phenotypic characteristics of MODY caused by hepatocyte nuclear nuclear factor 4 alpha mutations in a large European collection. Diabetologia 2005 48 : 878 885.
13. Gloyn AL, Pearson ER, Antcliff JF, Proks P, Bruining GJ, Slingerland AS et al. Activating mutations in the gene encoding the ATP-sensitive potassium channel subunit Kir6.2 and permanent neonatal diabetes. N Engl J Med 2004 350 : 1838 1849.
14. Slingerland AS, Hattersley AT. Mutations in the kir6.2 subunit of the Katp channel and permanent neonatal diabetes: new insights and new treatment. Ann Med 2005 37 : 186 195.
15. Pearson ER, Flechtner I, Njolstad PR, Malecki MT, Flanagan SE, Larkin B et al. Switching from insulin to oral sulphonylureas in patients with diabetes due to Kir6.2 mutations. N Engl J Med 2006 355 : 467 477.
16. Bury M. Chronic illness as biographical disruption. Sociol Health Illn 1982 4 : 167 182.
17. Shepherd M. Transforming lives: transferring patients with neonatal diabetes from insulin to sulphonylureas. Eur Diabetes Nurs 2006 3 : 137 142.
18. Van Manen M. Practising phenomenological writing. Phenomenol Pedagogy 1984 2, 1 : 36 69.
19. Van Manen M. Researching Lived Experience: Human Science for an Action Sensitive Pedagogy.
20. Aujoulat I, Marcolongo R, Bonadiman, Deccache A. Reconsidering patient empowerment in chronic illness: a critique of models of self-efficacy and bodily control. Soc Sci Med 2008 66 : 1228 1239.
21. Broom D, Whittaker A. Controlling diabetes, controlling diabetics: moral language in the management of diabetes type 2. Soc Sci Med 2004 58 : 2371 2382.